Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-24 @ 4:16 PM
NCT ID:
NCT06620666
Eligibility Criteria:
Inclusion Criteria:
* Sedentary adults (≥ 60 years), i.e., no physical exercise.
* Physically independent (able to walk 100 m without a walking aid and climb 10 steps without rest).
* Medical certificate of suitability or fitness to practice resistance training activities.
* Cognitive ability to understand and follow the instructions and sign the informed consent form.
* Free of any antioxidant supplements for at least six weeks before the start of this study: Vitamin C, Vitamin E, Vitamin A (beta-carotene), Zinc, Coenzyme Q (CoenzymeQ10), turmeric, Omega 3, creatine monohydrate or multivitamin products containing any of these compounds.
* Do not smoke more than 5 cigarettes per day or consume distilled alcoholic beverages on a daily basis.
Exclusion Criteria:
* Presence of cardiovascular, musculoskeletal, renal, liver, pulmonary, or neuromuscular and neurological disorders that would prevent the participant from performing the exercises.
* A history of malignant neoplasms.
* Terminal illness with life expectancy of less than one year.
* Mini mental State Examination lower than 23/30.
* Severe visual or hearing impairment.
* Body weight changes at 10% in the previous year.
* Intake of prescription medications or supplements (e.g., vitamins C, E) that were expected to alter the results of the study (ergogenic, dietary aids, estrogen, beta-blockers, steroid hormones, calcitonin, corticosteroids, glucocorticoids, thiazide diuretics, anticonvulsants, bisphosphonates, raloxifene).
* Current or prior (past six months) use of hormone replacement therapy.
* Engagement in regular strength training (more than once a week) during the previous six months.
* Participation in another research project (within the last six months) involving dietary, exercise, and/or pharmaceutical intervention.
* Not be under pharmacological treatment with allopurinol (trade name Zyloric).
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT06620666
Study Brief:
Protocol Section:
NCT06620666